A specimen analysis system includes at least one processor to receive image information that represents a respective plurality of pixels of an image of each of a plurality of testing areas to indicate the presence or absence of a test subject compound; to determine for each testing area a number of pixels that indicates either the presence or the absence of the test subject compound, if the number of pixels indicating positive for each of a plurality of testing areas equals or exceeds a first minimum threshold value indicating that the testing area is positive for either the presence or absence of the test subject compound, totaling all testing areas indicating positive for either the presence or absence of the test subject compound, and if the total number of the testing areas indicating positive for either the presence or absence of the test subject compound equals or exceeds a second minimum threshold value indicating an overall positive test result for either the presence or absence of the test subject compound.
Drawings
Claims20
A specimen analysis system to analyze specimen test articles that include a plurality of testing areas that indicate at least a presence or an absence of a test subject compound in a specimen, the specimen analysis system comprising:
at least one processor;
and
at least one non-transitory processor-readable medium that is communicatively coupled to the at least one processor and that stores at least one of processor-executable instructions or data that, when executed by the at least one processor, cause the at least one processor to:
receive a set of image information that represents an image of each of the plurality of testing areas, each of the testing areas represented by a respective plurality of pixels in the set of image information;
for each of the plurality of testing areas, determine a number of pixels that indicate as one of either the presence or the absence of the test subject compound;
for each of the testing areas, determine if the number of pixels that indicate one of either the presence or the absence of the test subject compound equals or exceeds a first minimum threshold value which indicates that the testing area is positive for one of either the presence or the absence of the test subject compound;
determine a number of testing areas that indicate positive for one of either the presence or the absence of the test subject compound;
and
determine if the number of testing areas that indicate positive for one of either the presence or the absence of the test subject compound equals or exceeds a second minimum threshold value which indicates an overall positive test result for one of either the presence or the absence of the test subject compound.
6 more elements
A computer-implemented method to analyze specimen test articles that include a plurality of testing areas that indicate at least a presence or an absence of a test subject compound in a specimen, the method comprising:
receiving, by one or more computing devices, a set of image information that represents an image of each of the plurality of testing areas, each testing area represented by a respective plurality of pixels in the set of image information;
and
for each of the testing areas determining, by the one or more computing devices, a number of pixels that indicate as one of either the presence or the absence of the test subject compound;
for each of the testing areas determining, by one or more computing devices, if the number of pixels that indicate as one of either the presence or the absence of the test subject compound equals or exceeds a first minimum threshold value which indicates that the testing area is positive for one of either the presence or the absence of the test subject compound;
determining, by the one or more computing devices, a number of testing areas that indicate positive for one of either the presence or the absence of the test subject compound;
and
determining, by the one or more computing devices, if the number of testing areas that indicate positive for one of either the presence or the absence of the test subject compound equals or exceeds a second minimum threshold value which indicates an overall positive test result for one of either the presence or the absence of the test subject compound.
16/322,844Filed 31 Jul 2017 · us provisional application
Priority
1 Aug 2016
Published
US 2021/0374946 A12 Dec 2021
Granted
12 Jul 2022
Term ends
11 Nov 2039Estimated · howhide20 years from earliest known nonprovisional domestic filing plus recorded patent term adjustment, including 833 days of adjustment. Maintenance-fee lapses, terminal disclaimers and statutory extensions have not been checked. The continuity chain may be incomplete; this is not an enforceability determination.
Image analysis: determination of colour characteristics
Life of this patent
About 13 years of term left · ends 11 Nov 2039 (estimated)
Priority1 Aug 2016
Filed31 Jul 2017
Published2 Dec 2021
Granted12 Jul 2022
Today12 Oct 2026
Term ends11 Nov 2039
Priority1 Aug 2016
Granted12 Jul 2022
Term ends11 Nov 2039
Priority claimedParent application 62/369,588
Application filedUS 16/322,844
PublishedUS 2021/0374946 A1
Assigned to Genprime, Inc.assignment of assignor's interest
GrantedUS 11,386,552 B2
TodayWithin its term
Term endsEstimated, includes 833 days of adjustment
Description12,150 words
Summary3,014 words
#The present disclosure generally relates to specimen analysis systems and, more particularly, to specimen analysis systems that optically assess specimen test articles.
#Specimen test articles may be used to determine a presence or absence of a test subject substance in a specimen (i.e., the principal substance for which the specimen is being tested). In particular, certain specimen test articles (e.g., lateral flow strips) include at least one optical test substance marker that optically indicates at least the presence or absence of the test subject substance in the specimen. For example, a color of the optical test substance marker may indicate the presence or absence of the test subject substance within the specimen. As one example, a color of the optical test substance marker may remain unchanged from a first color if the specimen does not contain the test subject substance, while the color of the optical test substance marker changes from the first color to a second, different color if the test subject substance is present within the specimen.
#Colorimetric response tests have been traditionally interpreted visually by a human operator. The resulting test colors of such colorimetric tests, however, can vary greatly in color intensity, thus leading to a highly subjective user interpretation. For example, one such colorimetric test is a Guaiac test used to detect hemoglobin in a fecal sample. The Guaiac test indicates the presence of hemoglobin by turning blue. In some instances, positive results may be indicated by indistinct blue auras surrounding the specimen test area. In some cases, operators may interpret this aura as sufficient to indicate a positive result. Other operators may interpret this aura as insufficient to indicate a positive result. In addition, colorimetric analysis typically includes multiple test areas that must indicate a positive response for a positive indication to be found. This is done to minimize false-positive results. However, some operators may nevertheless interpret a positive result when a vibrant colorimetric response is detected in only a single test area.
Brief description of the drawings9 figures
#In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not necessarily drawn to scale, and some of these elements may be arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn, are not necessarily intended to convey any information regarding the actual shape of the particular elements, and may have been solely selected for ease of recognition in the drawings.
#FIG. 1 is a block diagram of an example specimen analysis system, according to at least one illustrated embodiment.
#FIG. 2 is a flow chart diagram showing an example method to analyze specimen test articles, according to at least one illustrated embodiment.
Detailed description8,845 words
#In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures and methods (e.g., various components of computing devices, principles of operation of a lateral flow strip, etc.) have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
#Unless the context requires otherwise, throughout the specification and claims that follow, the word “comprising” is synonymous with “including,” and is inclusive or open-ended (i.e., does not exclude additional, unrecited elements or method acts).
#Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.